The Chinese Biopharmaceutical Association (CBA) is a non-profit organization made up of professionals who have an interest in bio-pharmaceutical research and/or technology development. CBA was established in 1995 and its headquarters are located in the State of Maryland, which is adjacent to the U.S. capital city of Washington D.C. The majority of CBA members are Chinese scientists, researchers, or professors. They work in government agencies, universities, research institutes as well as in the biotechnology and pharmaceutical industries. Some are conducting pioneering research with the National Institutes of Health (NIH), whereas others are directly involved in the government regulatory process as officers of the Food and Drug Administration (FDA) or in the field of intellectual property as patent attorneys or as patent examiners with the Patent and Trademark Office (PTO). CBA`s Executive Committee consists of research, regulatory and management professionals who, in aggregate, represent all sectors of the bio-pharmaceutical research and development communities and the industry’s regulatory agencies.
CBA is committed to promoting science, technology, and business development in the bio-pharmaceutical fields through information exchange and by fostering research and business collaborations. It brings scientists and business practitioners together and aims to establish links between basic and applied research, between academia and industry, and between researchers and entrepreneurs. CBA is also committed to facilitating all types of biopharmaceutical-focused collaborations between the United States and China.
www.cba-usa.org - 43440 - The Chinese Biopharmaceutical Association